In partnership with Life Sciences Queensland, the Brisbane Convention & Exhibition Centre has established a Bio-Innovation Bursary to support emerging biotechnology researchers and strengthen connections between research and industry.
The bursary was developed through the BCEC Advocates Partnership to support Queensland and Australia’s research and commercial uptake across health, biomedical and agritech bio-innovation. As a leading host of international life sciences and biotechnology conferences, BCEC has spend three decades connecting science leaders, researchers and industry. The bursary honours this legacy by investing in future talent and supporting research translation to industry.
Valued at up to $25,000, recipients will have the opportunity to build on their research and extend its reach, building momentum at a pivotal point in their career.
MEET THE INAUGURAL RECIPIENT
The inaugural BCEC LSQ Bio-Innovation Bursary has been awarded to Dr Chris McMillan, a University of Queensland virologist and vaccinologist.
His research focuses on innovative vaccine platforms and advanced delivery technologies addressing viruses of global health importance. Through his project, Full Circle: LNP-free microarray patch RNA vaccines, Dr McMillan will collaborate with Queensland biotechnology company Vaxxas to advance RNA vaccine delivery using needle-free, high density microarray patch technology.
The project brings together Queensland research and industry expertise to explore a new approach to vaccine delivery, supporting the translation of promising science towards practical application.